ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding ADC Therapeutics SA changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 106 | 115 | +9 |
| Shares | 67.8M | 82.9M | +15.0M (+22.2%) |
| Value | $271.3M | $292.8M | +$21.5M (+7.9%) |
New holders (21)
Institutions that held ADC Therapeutics SA at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Eventide Asset Management, LLC | 3,364,067 | $11.9M | 0.19% |
| Schroder Investment Management Group | 418,782 | $1.47M | 0.00% |
| D. E. Shaw & Co., Inc. | 263,071 | $928.6K | 0.00% |
| Two Sigma Advisers, LP | 120,567 | $425.6K | 0.00% |
| State of Wisconsin Investment Board | 113,369 | $400.2K | 0.00% |
| Kingswood Wealth Advisors, LLC | 105,000 | $370.6K | 0.02% |
| Cantor Fitzgerald, L. P. | 100,000 | $353.0K | 0.01% |
| SG Americas Securities, LLC | 24,448 | $86.0K | 0.00% |
| Callan Family Office, LLC | 23,842 | $84.2K | 0.00% |
| Gsa Capital Partners LLP | 20,889 | $74.0K | 0.01% |
| Susquehanna International Group, LLP | 20,178 | $71.2K | 0.00% |
| Henrickson Nauta Wealth Advisors, Inc. | 19,411 | $68.7K | 0.01% |
| Axq Capital, LP | 16,078 | $56.8K | 0.01% |
| Engineers Gate Manager LP | 12,071 | $42.6K | 0.00% |
| Quantinno Capital Management LP | 10,825 | $38.2K | 0.00% |
| Los Angeles Capital Management LLC | 1,725 | $7.99K | 0.00% |
| GAMMA Investing LLC | 492 | $1.74K | 0.00% |
| Group One Trading, L.P. | 100 | $353 | 0.00% |
| Farther Finance Advisors, LLC | 57 | $201 | 0.00% |
| MAI Capital Management | 16 | $57 | 0.00% |
| Rothschild Investment LLC | 10 | $35 | 0.00% |
Sold out (12)
Institutions that held ADC Therapeutics SA at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Lynx1 Capital Management LP | 1,325,848 | $5.30M |
| Opaleye Management Inc. | 682,529 | $2.73M |
| Heights Capital Management, Inc | 326,766 | $1.31M |
| Walleye Capital LLC | 177,032 | $708.1K |
| Marshall Wace, LLP | 159,993 | $640.0K |
| HRT Financial LP | 27,531 | $110.0K |
| R Squared Ltd | 14,714 | $58.9K |
| Diversified Trust Co | 14,115 | $56.5K |
| Atom Investors LP | 13,131 | $52.5K |
| UMA Financial Services, Inc. | 228 | $912 |
| Clearstead Advisors, LLC | 1 | $4 |
| TSFG, LLC | 100 | $0 |